Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells

By Abu-Raya S.   Tabakman R.   Blaugrund E.   Trembovler V.   Lazarovici P.  

European Journal of Pharmacology, Vol. 434, Iss. 3, 2002-01 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite

Monoamine Oxidase-B Inhibition in Alzheimer's Disease

By Riederer P.   Danielczyk W.   Grunblatt E.  

Neurotoxicology, Vol. 25, Iss. 1, 2004-01 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

QSAR and Molecular Docking Techniques for the Discovery of Potent Monoamine Oxidase B Inhibitors: Computer-Aided Generation of New Rasagiline Bioisosteres

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 16, 2012-08 ,pp. : 1734-1747

Bentham Science Publishers

Access to resources Recommend Favorite

Pirlindole: A Selective Reversible Inhibitor of Monoamine Oxidase a. A Review of Its Preclinical Properties

By Bruhwyler J.   Liegeois J.F.   Geczy J.  

Pharmacological Research, Vol. 36, Iss. 1, 1997-07 ,pp. : 23-33

Academic Press

Access to resources Recommend Favorite

Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission

By Haddjeri N.   De Montigny C.   Curet O.   Blier P.  

European Journal of Pharmacology, Vol. 343, Iss. 2, 1998-02 ,pp. : 179-192

Elsevier

Access to resources Recommend Favorite